Website in archive mode. Questions? Email [email protected]

  Linde PLC ( LIN ) |
2018 - 2021 (4 years)

Net Revenue (Sales) is 
$21.1B (1Y -23.4% )

LIN Stock Price & Net Revenue (Sales)

Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $7.3B -0.4x
( -11.8% / year avg)
chevron_left 2018 $12.0B
vertical_align_top Peak $27.0B +2.72x
vertical_align_bottom Bottom $7.3B
arrow_drop_up # Up Years 3 3 of 4
years up.
arrow_drop_down # Down Years 1
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • LIN's stock price has rallied +5,784% from $4.23 in 2018 , or -142.1x faster than it's net revenue (sales) over the same period.
  • If LIN shrinks it's stock at the same rate as it's net revenue (sales) (-11.8%/year) , it's stock price will shrink +28.5% and hit $70.89 over the next 10 years.
  • LIN's stock price has gone up 1 of the 3 years (+33%) it's net revenue (sales) were also up.
5-Year Change 🚀
+144%$16.2BCost of Revenue (Sales)
-413.8%-$16.2BGross Profit Margin
+45.8%$140.0MResearch and Development (R&D)
+152%$3.1BSelling, General, and Administrative (SG&A)
-150.0%$16.0MOther Income/Expenses, Net
+27.0%$3.3BTotal Operating Expenses
+110%$19.5BCost & Expenses
-51.2%-$80.0MInterest Expense/Income, Net
+279%$4.7BDepreciation & Amortization (D&A)
+51.6%$5.7BEBITDA
-58.1%$1.1BOperating Income
-100.1%$16.0KTotal Other Income/Expenses
+108%$5.0BPretax Income (Earnings)
+3,663%$5.0BNet Income (Earnings)
+1,987%9.47Earnings Per Share (EPS)
+1,969%9.39Earnings Per Share (EPS) Diluted
+80.3%$2.1BShares Outstanding
+81.9%$2.1BShares Outstanding (Diluted)
  • Line Item (in $M) FY 2020 FY 2019 FY 2018
    1 Revenue 27243000000 28228000000 14836000000
    2 Cost of Revenue 15383000000 16644000000 9020000000
    3 Gross Profit (Income) 11860000000 11584000000 5816000000
    4 R&D 152000000 184000000 113000000
    5 SG&A 1890000000 3457000000 1629000000
    6 Other Expenses -279000000.00 -3000000.00 -10000000.00
    7 Operating Expenses 7971000000 8316000000 3572000000
    8 Interest Expense 255000000 38000000 202000000
    9 D&A 4626000000 4675000000 1830000000
    10 EBITDA 8515000000 7608000000 7077000000
    11 Operating Income 3889000000 2933000000 5247000000
    12 Other Income Expenses (Net) -390000000.00 128000000.00 24000000.00
    13 Pre-Income Tax 3384000000 2927000000 5049000000
    14 Income Tax Expense 847000000 769000000 817000000
    15 Net Income 2501000000 2285000000 4381000000
    16 EPS 4.59 4.19 13.11
    17 EPS Diluted 4.59 4.19 13.11
    18 Shares Outstanding 524442000 545170000 334127000
    19 Shares Outstanding (Diluted) 529038000 545170000 334127000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018
    1 Cash & Cash Equivalents 3754000000 2700000000 4466000000
    2 Short Term Investments 2061000000.00 0.00 0.00
    3 Cash & S-T Investments 3754000000 2700000000 4466000000
    4 Accounts Receivables 4590000000 4690000000 4580000000
    5 Inventory 1729000000 1697000000 1651000000
    6 Other Current Assets 221000000 1265000000 6575000000
    7 Total Current Assets 10924000000 10352000000 17272000000
    8 PP&E 29801000000 30089000000 29717000000
    9 Goodwill 28201000000 27019000000 26874000000
    10 Intangible Assets 16184000000 16137000000 16223000000
    11 Goodwill & Intangible Assets 44385000000 43156000000 43097000000
    12 L-T Investments 2061000000 2067000000 1914000000
    13 Tax Assets 268000000 7236000000 7611000000
    14 Other Non-Current Assets 278000000 798000000 1251000000
    15 Total Non-Current Assets 77305000000 76260000000 76114000000
    16 Other Assets 4209000000.00 0.00 0.00
    17 Total Assets 88229000000 86612000000 93386000000
    18 Accounts Payables 3095000000 3266000000 3219000000
    19 S-T Debt 4002000000 2267000000 2179000000
    20 Income Tax Payables 0.00 370000000.00 657000000.00
    21 Deferred Revenue 1769000000.00 1758000000.00 1546000000.00
    22 Other Current Liabilities 1205000000 3431000000 4526000000
    23 Total Current Liabilities 13740000000 12160000000 12956000000
    24 L-T Debt 12152000000 10693000000 12288000000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018
    1 Net Income (Earnings) 2501000000 2285000000 4381000000
    2 D&A 4626000000 4675000000 1830000000
    3 Deferred Income Tax -369000000 -303000000 -187000000
    4 Stock-Based Compensation (SBC) 133000000.00 95000000.00 62000000.00
    5 Change in Working Capital -1008000000 -6124000000 4338000000
    6 Accounts Receivables 19000000.00 80000000.00 -124000000.00
    7 Inventory 18000000.00 -81000000.00 -4000000.00
    8 Accounts Payables 0.00 -174000000.00 287000000.00
    9 Other Working Capital -2816000000 -1808000000 4316000000
    10 Other Non-Cash Items 440000000 -308000000 -2384000000
    11 Net Cash Provided by Operating Activities 7429000000 6188000000 3702000000
    12 Investments in PP&E 0.00 0.00 0.00
    13 Acquisitions (Net) -68000000.00 -225000000.00 -25000000.00
    14 Purchase of Investments 0.00 -2658000000.00 -599000000.00
    15 Sales/Maturities of Investments 0.00 0.00 0.00
    16 Other Investing Activities 0.00 7754000000.00 7845000000.00
    17 Net Cash used for Investing Activities -2986000000 1189000000 5363000000
    18 Debt Repayment -2681000000.00 -1583000000.00 -3124000000.00
    19 Common Stock Issued 47000000.00 72000000.00 77000000.00
    20 Common Stock Repurchased -2457000000 -2586000000 -522000000
    21 Dividends Paid -2028000000 -1891000000 -1166000000
    22 Other Financing Activities -220000000.00 -2937000000.00 -186000000.00
    23 Net Cash Used Provided by Financing Activities -3345000000 -8992000000 -4996000000
    24 Net Change in Cash 1054000000 -1752000000 3986000000
  • About
    Industry: Specialty Chemicals
    Sector: Basic Materials
    Country: GB
    IPO Date: 10/29/2018
    Stonk Exchange: NYSE
    • Linde Plc engages in the production and distribution of industrial gases.
    • The company is headquartered in Guildford, Surrey and currently employs 80,204 full-time employees.
    • The firm provides atmospheric gases (oxygen, nitrogen, argon and rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene).
    • The company designs, engineers and builds equipment that produces industrial gases primarily for internal use.
    • The company also offers gaseous medication and related medical products and devices for patients and medical staff.
    • The firm serves the customers in various industries, including healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals and water treatment.



Looking for a specific stock? Please use our search ("TSLA, AAPL, SPY...") at the top. Otherwise, you can refer to the lists below.
List of all stocks by first letter/number.